Patent US4444752A successfully refreshed from Google Patents.
US4444752A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for treating progressive systemic sclerosis
Assignee: Lescarden Ltd
•
Filing: 1982-09-13
•
Granted: 1984-04-24
•
Expires: 2002-09-13
Abstract
Abstract Disclosed herein is a method for the treatment of progressive systemic sclerosis by the oral administration of a pharmaceutical formulation containing finely divided cartilage powder.
Inventors
- 👤 John F. Prudden
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 02:00
CPC Classifications
A; A61; A61K; A61K35/00; A61K35/56; A61K35/60; A61K35/12; A61K35/32
Claims Analysis
Total Claims: 17
Claim 1
Independent Claim
35 words
A method of treating progressive systemic sclerosis in a patient afflicted with progressive systemic sclerosis which comprises orally administering to said patient an effective amount for treating progressive systemic sclerosis a finely divided cartilage extract.
Claim 2
Independent Claim
35 words
A method of treating progressive systemic sclerosis in a patient afflicted with progressive systemic sclerosis which comprises orally administering to said patient an effective amount for treating progressive systemic sclerosis a finely divided cartilage extract.
Claim 3
Dependent Claim
24 words
The method of claim 1 wherein said effective amount comprises between about nine and about twenty grams of finely divided cartilage extract per day.
Claim 4
Dependent Claim
17 words
The method of claim 1 wherein said effective amount is delivered in divided dosages throughout the day.
Claim 5
Dependent Claim
16 words
The method of claim 2 which comprises administering said cartilage extract in a solid dosage form.
Claim 6
Dependent Claim
13 words
The method of claim 4 wherein said solid dosage form is a capsule.
Claim 7
Dependent Claim
13 words
The method of claim 4 wherein said solid dosage form is a tablet.
Claim 8
Dependent Claim
18 words
The method of claim 6 wherein said capsule contains between about 50 and 500 milligrams of said extract.
Claim 9
Dependent Claim
17 words
The method of claim 6 wherein said cartilage extract is acid-pepsin digested and derived from bovine trachea.
Claim 10
Dependent Claim
14 words
The method of claim 7 wherein said cartilage extract is derived from shark cartilage.
Claim 11
Dependent Claim
15 words
The method according to claim 7 wherein said capsule contains 375 milligrams of cartilage extract.
Claim 12
Dependent Claim
20 words
The method of claim 4 which comprises administering said cartilage extract orally in the form of a solution, or suspension.
Claim 13
Independent Claim
41 words
A method of improving joint mobility in a mammal affected with progressive systemic sclerosis which comprises orally administering to said mammal afflicted with said progressive systemic sclerosis an effective amount for improving joint mobility of an extract derived from granulated cartilage.
Claim 14
Independent Claim
41 words
A method of improving joint mobility in a mammal affected with progressive systemic sclerosis which comprises orally administering to said mammal afflicted with said progressive systemic sclerosis an effective amount for improving joint mobility of an extract derived from granulated cartilage.
Claim 15
Independent Claim
47 words
A method of alleviating skin tension in mammals afflicted with progressive systemic sclerosis with comprises orally administering to said mammals an effective amount for alleviating skin tension in a mammal afflicted with progressive systemic sclerosis of a cartilage product derived from granulated animal, reptile or fish cartilage.
Claim 16
Independent Claim
47 words
A method of alleviating skin tension in mammals afflicted with progressive systemic sclerosis with comprises orally administering to said mammals an effective amount for alleviating skin tension in a mammal afflicted with progressive systemic sclerosis of a cartilage product derived from granulated animal, reptile or fish cartilage.
Claim 17
Dependent Claim
18 words
The method of claim 13 wherein said effective amount comprises between approximately 9-60 grams of said cartilage product.
References Cited (Backward Citations)
US3400199A
Cited
US3966908A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-04-24 | 1987-10-24 | 1988-04-24 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-04-24 | 1991-10-24 | 1992-04-24 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-04-24 | 1995-10-24 | 1996-04-24 | $7700.00 | Window Closed / Lapsed |